Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Partner Company Shares

11 Oct 2019 07:00

RNS Number : 5522P
Amphion Innovations PLC
11 October 2019
 

 

AMPHION INNOVATIONS PLC

 ("Amphion" or "the Company")

 

 

Sale of Partner Company Shares

 

London and New York, 11 October 2019 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that Amphion's total holding in Polarean Imaging plc ("Polarean") of 15,972,523 shares has been sold ("Sale") by the lender of its loan facility (the "Lender" and the "Facility"). The terms of the Facility were originally announced on 5 June 2014 and most recently amended as announced on 25 September 2019. As previously announced, Amphion's holding in Polarean shares was pledged as security against the Facility and the shares were sold pursuant to this security arrangement.

 

The last reported loan balance of the Facility was US $2.3 million (excluding the Lender's share of the pledged share price appreciation which is currently approximately £172,500). Amphion does not yet have full details of the application of the Sale proceeds, however total proceeds are estimated at approximately US $2.5 million.

 

Amphion remains highly cash constrained however the Directors had hoped to avoid significant sales of Polarean shares whilst Amphion considers both its short term and medium financing options and works with its debt providers. The Directors consider it to be unfortunate that repayment of the Facility required the sale of Amphion's shares in Polarean. Amphion remains committed to Polarean's success and looks forward to supporting the company in the future.

 

Further to the Company's announcement on 27 June 2019, the Company's shares remaining suspended from trading on AIM. The Company expects to make a further announcement when it has more details on the Sale and on the Facility balance.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").

 

 

For further information please contact:

 

Amphion Innovations

Tel: +1 (212) 210 6224

Charlie Morgan

Panmure Gordon Limited (Nominated Adviser and Corporate Broker)

Tel: +44 (0)20 7886 2500

Emma Earl/ Freddy Crossley (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)

SP Angel Corporate Finance LLP (Joint Corporate Broker)

Tel: +44 (0) 20 3470 0470

David Hignell (Corporate Finance)

Vadim Alexandre (Corporate Broking)

Walbrook PR

Tel: +44 (0)20 7933 8780 or amphion@walbrookpr.com

Anna Dunphy / Paul McManus

 

About Amphion Innovations plc

 

Amphion Innovations is a developer of medical, life science and technology businesses.

 

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in a few Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.

 

On the web: www.amphionplc.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISMMBBTMBBBTLL
Date   Source Headline
23rd Jul 20127:00 amRNSDirectors Dealings
20th Jul 201212:00 pmRNSFunding Update
20th Jul 20127:00 amRNSTrading Statement
11th Jun 20127:00 amRNSFinal Results
9th May 20129:20 amRNSFunding update
1st May 20127:00 amRNSPartner Company Update
28th Mar 20127:00 amRNSPartner Company Update
28th Feb 20127:00 amRNSDirector Dealings
23rd Feb 20124:36 pmRNSFunding Update
3rd Feb 20123:24 pmRNSFunding Update
2nd Feb 20127:00 amRNSPatent Approval
30th Dec 20117:00 amRNSDirector Dealings
6th Dec 20119:09 amRNSDirector/PDMR Shareholding
21st Nov 20118:42 amRNSNew Suits Filed and New Debt Facilites
29th Sep 20117:00 amRNSHalf Yearly Report
21st Sep 20117:00 amRNSNotice of Results
9th Sep 20117:00 amRNSIssue of Equity
2nd Aug 20117:00 amRNSTrading Statement
28th Jul 20117:00 amRNSAdjournment of AGM
22nd Jul 20118:20 amRNSDirector/PDMR Shareholding
21st Jul 20119:03 amRNSDirector/PDMR Shareholding
30th Jun 20117:00 amRNSFinal Results
21st Jun 20114:44 pmRNSNew Debt Facility
24th May 20117:00 amRNSDisposal
15th Apr 20119:19 amRNSNew debt facility
14th Apr 20117:00 amRNSNotice of Results
13th Apr 20117:00 amRNSUpdate on Data Tern Patent Litigation
30th Mar 20117:00 amRNSIP Licences and Directorate Change
28th Feb 20117:00 amRNSTrading Statement
6th Jan 20117:00 amRNSChange of Adviser
5th Jan 20117:00 amRNSIP License Agreements
9th Dec 20107:00 amRNSNew Debt Facility
25th Oct 20107:00 amRNSPartner Update
18th Oct 20103:50 pmRNSDirector/PDMR Shareholding
30th Sep 20104:19 pmRNSTotal Voting Rights
24th Sep 20107:00 amRNSIP Licensing
22nd Sep 20108:00 amRNSGrant Win by Partner Company Firestar
10th Sep 20107:00 amRNSHalf Yearly Report
8th Sep 20107:00 amRNSIssue of Equity
2nd Aug 20102:54 pmRNSTotal Voting Rights
30th Jun 20107:00 amRNSIssue of Equity
29th Jun 20107:00 amRNSPartner Company Kromek acquires US Company
8th Jun 20107:00 amRNSAGM Statement
18th May 20107:00 amRNSDirector/PDMR Shareholding
30th Mar 20103:21 pmRNSDirector/PDMR Shareholding
16th Mar 20107:00 amRNSFinal Results
15th Mar 20107:00 amRNSPartner Company Kromek Completes Fundraising
8th Mar 20107:00 amRNSNotice of Results
2nd Feb 20107:00 amRNSTrading Update
6th Jan 20107:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.